Skip to main content

TIDEWATER

LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer’s Disease Presented at the Alzheimer’s Association International Conference® (AAIC®) 2026

New clinical and real-world data support a subcutaneous treatment pathway from initiation through maintenance treatment, offering dosing convenience for patients and care partnersTOKYO and CAMBRIDGE, Mass., July 12, 2026 /PRNewswire/ — Eisai Co., Ltd. and Biogen Inc. (Nasdaq:…

GAC Group to Celebrate 30 Million Global Users on July 16

GUANGZHOU, China, July 12, 2026 /PRNewswire/ — From the roll-off of its first vehicle to the upcoming milestone of its 30 millionth finished automobile, every step forward taken by GAC stems from the choices and trust of users worldwide.…

FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2026

FORMER ELITE SOCCER PLAYERS SHOWEVIDENCE OF BRAIN HEALTH CHANGES IN MID-LIFEKey TakeawaysNew research provides insights into brain health among former elite professional soccer players during midlife. Former players reported high levels of depression, anxiety, and subjective difficulties with…

/C O R R E C T I O N — 7-Eleven, Inc./

In the news release, Save the Date: 7-Eleven, Inc. Celebrates 60 Years of Slurpee® Tomorrow with Free Drinks and a New Flavor on the Coolest Slurpee Day Yet, issued 10-Jul-2026 by 7-Eleven, Inc. over PR Newswire, we are…